Research, not signals.
A multi-agent research workspace for self-directed investors. Five analyst agents produce side-by-side analysis on any instrument you choose. You read the evidence and decide.
AI-generated analysis, not investment advice. Outputs are produced by generative models, can contain errors, and should be independently verified before any decision.
5
Analyst agents per report
9
Investors on the waitlist
7
Scoring dimensions — all published
See Acutic in motion
Five specialised AI agents analyse each instrument independently.
Example data — not live
Values are illustrative. Acutic does not pre-select instruments for you.
Example Corp
EXMPTechnology · Large Cap · US-listed
Overall
Score / 100
AI-generated analysis — not investment advice. Outputs can contain errors and should be independently verified.
Five Analyst Agents
Fundamental Analyst
72/100Revenue growth of 8.3% YoY; operating margin at 31.2%. Free cash flow yield 4.1% — above the sector median of 2.6%.
Technical Analyst
68/100Price is trading above the 200-day moving average. RSI at 54 — neutral range. Average daily volume in line with the 30-day baseline.
Macro Context Analyst
61/100Sector facing headwinds from elevated real rates. USD strength is a factor for international revenue exposure (approx. 57% of revenue ex-US).
News Sentiment Analyst
74/100Recent earnings call transcript: management tone neutral-to-positive. No material negative news events in the trailing 30-day window.
Risk Analyst
55/100Concentration risk: top 3 product lines represent 68% of revenue. Regulatory exposure noted in two jurisdictions. Debt/EBITDA at 1.8×.
Key Findings
- →Free cash flow yield (4.1%) is above the sector median (2.6%) for the trailing twelve months.
- →International revenue exposure (approx. 57%) creates sensitivity to USD strength versus a basket of major currencies.
- →Regulatory inquiries in two jurisdictions are disclosed in the most recent annual filing; no financial penalties recorded to date.
AI-generated analysis, not investment advice. Outputs can contain errors and should be independently verified.
How It Works
From a ticker to a structured thesis
Bring an idea
Type a ticker — AAPL, NVDA, anything you have been looking at. Acutic does not pre-select instruments for you; you decide what to research.
Five agents analyse it
Specialised AI analysts examine fundamentals, technicals, news sentiment, and risk factors in parallel — producing a side-by-side report you can read in minutes.
Read the evidence
Every claim carries a footnote and a methodology link. Scores are reproducible. Disagreements between agents are surfaced, not hidden.
Track your thinking
Build a thesis in the journal, monitor watchlist instruments for factual changes, and evaluate whether your reasoning held up over time. The decisions are yours.
Features
A research workspace, not a signal feed.
Acutic is investment research and analysis software. Five analyst agents examine instruments side-by-side; the methodology is public; the user makes every decision.
Multi-Agent Research Theater
Five analyst agents examine any instrument in parallel — fundamentals, technicals, risk, news sentiment, and quality — producing a side-by-side report you can read in minutes.
Bring Me Your Idea
Type the tickers you have been considering. Acutic runs the full multi-agent research on each one. Same depth on what you choose, not what we choose.
AI Sparring Partner
Stress-test a thesis. The AI plays bear: the most credible counter-arguments to any instrument or position, with cited fundamentals and risk factors.
Thesis Builder
Author a structured investment thesis — bull case, bear case, falsification triggers — with AI providing factual research as raw material. The thesis is yours; we supply the evidence.
Score Backtests
Public methodology accuracy. Historical aggregate returns by score band — so you can see how the scoring engine has actually behaved over time.
Market Screener
Filter the stock universe by objective criteria: industry, market cap, valuation, growth, quality. Equal-weight ranking — no profile-based highlighting.
Watchlist & Daily Digest
Track instruments you care about. Each morning the digest surfaces factual deltas — earnings releases, score changes, news events — with no action verbs and no synthesis on your behalf.
Trade Journal
Log decisions as you make them. Acutic does not place trades. The journal lets you record what you did, why, and evaluate whether the reasoning held up.
Evaluation Loop
After 7, 30, 90, 180, and 365 days, Acutic measures the quality of your decision process — not just outcomes. See which parts of your reasoning were sound, separately from market noise.
AI-generated analysis, not investment advice. Outputs are produced by generative models, can contain errors, and should be independently verified before any decision.
Who this is for
Built for a specific kind of investor
Acutic is a research workspace, not a tip service. It earns its place for some investors and not others — here is the honest split, so you can decide before you sign up.
Built for you if…
- You manage a real portfolio — roughly €15K or more — and the decisions actually matter to you.
- You have been investing for two years or longer, so you already have a process you want to sharpen.
- You already pay for at least one research tool, because you value evidence over a hot take.
- You break your own rules sometimes, and you want a journal that holds you to them.
Not built for you if…
- You are a pure index-fund investor — a single VWCE or VOO position is your whole plan.
- You are a day trader looking for intraday entries and exits.
- You are a complete beginner who has not placed a first trade yet.
- You are looking for stock tips or a list of names to act on.
These are descriptions of an investing approach, not a personalised fit verdict. Acutic provides research and educational analysis — not investment advice. You make your own decisions.
Pricing
Free during beta. Tier structure locked; prices announced at launch.
Join the waitlist for full beta access at no cost. Tier names and feature sets are confirmed. Euro pricing will be announced before public launch.
Solo
Free during beta
Used by investors exploring AI research for the first time.
- Multi-agent research on any instrument
- Watchlist with daily factual digest
- Trade journal and evaluation loop
- Market screener
Active
Pricing announced at launch
Used by investors running more research and more theses.
- Everything in Solo
- Higher monthly research limits
- AI Sparring Partner sessions
- Priority support
Professional
Pricing announced at launch
Used by research-heavy practitioners managing larger portfolios.
- Everything in Active
- API access (read-only)
- Extended score history
- Methodology export
Tier names and feature sets are confirmed. Euro pricing will be announced before public launch. Beta access remains free until then.
Roadmap
Where we are. Where we're going.
Tier 1
Live- ·Authentication and investment profile
- ·Strategy template gallery
- ·Stock universe and screener
- ·Multi-agent research on any instrument
- ·Research page — candlestick charts, indicators & news
- ·Watchlist with portfolio tracking
- ·Portfolio position monitoring & analysis
- ·Dividend calendar
- ·Trade journal
- ·Daily factual digest
- ·Score backtests & public methodology
Tier 2
In Progress- ·AI Sparring Partner — bear-case analysis
- ·Bring Me Your Idea — onboarding research run
- ·Multi-currency holdings dashboard
- ·Multilanguage support (EN / DE / TR)
Tier 3
Planned- ·Thesis Builder Wizard
- ·Read-only API for paid tiers
- ·iOS & Android mobile app
- ·Additional market data providers
FAQ
Common questions
Research, not signals.
Join the waitlist to be among the first to access the multi-agent research workspace when we launch.
Request Early Access